T-518
T-518 is an orally active, BBB-penetrant and potent DFMO-based HDAC6 inhibitor with high selectivity (IC50 = 36 nM) . T-518 improves axonal transport. T-518 ameliorates object recognition deficit. T-518 can be studied in research for Alzheimer’s disease and tauopathy[1][2].
Product Specifications
CAS Number
[2276680-91-0]
UNSPSC
12352005
Target
HDAC; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/t-518.html
Purity
98.40
Solubility
10 mM in DMSO
Smiles
O=C(C(F)(F)C(F)(F)F)N[C@H]1[C@H](N2CC3=NC=C(C4=NN=C(C(F)F)O4)C=C3C2=O)CCCC1
Molecular Formula
C19H16F7N5O3
Molecular Weight
495.35
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CLC, CT (CLC, Eosinophil lysophospholipase, Charcot-Leyden crystal protein, Galectin-10, Lysolecithin acylhydrolase) (MaxLight 750) discontinued
